1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Vision Care Overview

3 Products under Development
3.1 Vision Care - Pipeline Products by Stage of Development
3.2 Vision Care - Pipeline Products by Segment
3.3 Vision Care - Pipeline Products by Territory
3.4 Vision Care - Pipeline Products by Regulatory Path
3.5 Vision Care - Pipeline Products by Estimated Approval Date
3.6 Vision Care - Ongoing Clinical Trials

4 Vision Care - Pipeline Products under Development by Companies
4.1 Vision Care Companies - Pipeline Products by Stage of Development
4.2 Vision Care - Pipeline Products by Stage of Development

5 Vision Care Companies and Product Overview
5.1 2C Tech Corporation Inc Company Overview
5.1.1 2C Tech Corporation Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 2Eyes vision SL Company Overview
5.2.1 2Eyes vision SL Pipeline Products & Ongoing Clinical Trials Overview
5.3 Advanced Medical Electronics Corp Company Overview
5.3.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 Adventus Technology Inc Company Overview
5.4.1 Adventus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Aeon Astron Corporation Company Overview
5.5.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.6 Aequus Pharmaceuticals Inc Company Overview
5.6.1 Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Ai Kangte Medical Technology Co Ltd Company Overview
5.7.1 Ai Kangte Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Alcon Inc Company Overview
5.8.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Allotex Inc Company Overview
5.9.1 Allotex Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Apeliotus Ophthalmics (Inactive) Company Overview
5.10.1 Apeliotus Ophthalmics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.11 Axcelon Biopolymers Corp. Company Overview
5.11.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
5.12 Azalea Vision Company Overview
5.12.1 Azalea Vision Pipeline Products & Ongoing Clinical Trials Overview
5.13 Bar-Ilan University Company Overview
5.13.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
5.14 Bausch & Lomb Inc Company Overview
5.14.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Biel Glasses SL Company Overview
5.15.1 Biel Glasses SL Pipeline Products & Ongoing Clinical Trials Overview
5.16 Bionic Sight LLC Company Overview
5.16.1 Bionic Sight LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 Bionic Vision Australia Company Overview
5.17.1 Bionic Vision Australia Pipeline Products & Ongoing Clinical Trials Overview
5.18 Bionic Vision Technologies Pty Ltd Company Overview
5.18.1 Bionic Vision Technologies Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.19 Bionode LLC Company Overview
5.19.1 Bionode LLC Pipeline Products & Ongoing Clinical Trials Overview
5.20 Clerio Vision Inc Company Overview
5.20.1 Clerio Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Consejo Superior de Investigaciones Cientificas Company Overview
5.21.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview
5.22 CooperVision Inc Company Overview
5.22.1 CooperVision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 Cornea Biosciences Company Overview
5.23.1 Cornea Biosciences Pipeline Products & Ongoing Clinical Trials Overview
5.24 Corneat Vision Ltd Company Overview
5.24.1 Corneat Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 DeepOptics Company Overview
5.25.1 DeepOptics Pipeline Products & Ongoing Clinical Trials Overview
5.26 Euclid Systems Corp Company Overview
5.26.1 Euclid Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
5.27 e-Vision Medical Devices, Inc. Company Overview
5.27.1 e-Vision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.28 Eyenovations Company Overview
5.28.1 Eyenovations Pipeline Products & Ongoing Clinical Trials Overview
5.29 EyeYon Medical Company Overview
5.29.1 EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview
5.30 Forschungszentrum Julich GmbH Company Overview
5.30.1 Forschungszentrum Julich GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.31 iBionics Inc Company Overview
5.31.1 iBionics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Imperial College London Company Overview
5.32.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.33 Industrial Science & Technology Network Inc Company Overview
5.33.1 Industrial Science & Technology Network Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Innovega Inc Company Overview
5.34.1 Innovega Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Institute of Photonic Sciences Company Overview
5.35.1 Institute of Photonic Sciences Pipeline Products & Ongoing Clinical Trials Overview
5.36 iSTAR Medical SA Company Overview
5.36.1 iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
5.37 Johns Hopkins University Company Overview
5.37.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.38 Johnson & Johnson Vision Care Inc Company Overview
5.38.1 Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview
5.39 Kubota Vision Inc Company Overview
5.39.1 Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.40 Laclaree Vision Company Overview
5.40.1 Laclaree Vision Pipeline Products & Ongoing Clinical Trials Overview
5.41 Lipocoat BV Company Overview
5.41.1 Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview
5.42 Luminopia Inc Company Overview
5.42.1 Luminopia Inc Pipeline Products & Ongoing Clinical Trials Overview
5.43 Lynthera Corp Company Overview
5.43.1 Lynthera Corp Pipeline Products & Ongoing Clinical Trials Overview
5.44 MAG Optics Inc Company Overview
5.44.1 MAG Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.45 Massachusetts Eye and Ear Infirmary Company Overview
5.45.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
5.46 McGill University Company Overview
5.46.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview
5.47 McGowan Institute for Regenerative Medicine Company Overview
5.47.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
5.48 Mercy Health Research Company Overview
5.48.1 Mercy Health Research Pipeline Products & Ongoing Clinical Trials Overview
5.49 Meta Biomed Co Ltd Company Overview
5.49.1 Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.50 Mojo Vision Inc Company Overview
5.50.1 Mojo Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.51 Monash University Company Overview
5.51.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview
5.52 Nano Retina, Inc. Company Overview
5.52.1 Nano Retina, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.53 National University of Singapore Company Overview
5.53.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
5.54 Novartis AG Company Overview
5.54.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
5.55 Ocular Dynamics, LLC Company Overview
5.55.1 Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.56 OcuMedic Inc Company Overview
5.56.1 OcuMedic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.57 Ocutec Ltd Company Overview
5.57.1 Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.58 Ocutrx Vision Technologies LLC Company Overview
5.58.1 Ocutrx Vision Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.59 Okayama University Company Overview
5.59.1 Okayama University Pipeline Products & Ongoing Clinical Trials Overview
5.60 OPIA Technologies SAS Company Overview
5.60.1 OPIA Technologies SAS Pipeline Products & Ongoing Clinical Trials Overview
5.61 Oxsight Ltd Company Overview
5.61.1 Oxsight Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.62 PixelOptics Inc Company Overview
5.62.1 PixelOptics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.63 Pixium Vision SA Company Overview
5.63.1 Pixium Vision SA Pipeline Products & Ongoing Clinical Trials Overview
5.64 Pohang University of Science And Technology Company Overview
5.64.1 Pohang University of Science And Technology Pipeline Products & Ongoing Clinical Trials Overview
5.65 Presbia Plc Company Overview
5.65.1 Presbia Plc Pipeline Products & Ongoing Clinical Trials Overview
5.66 Queensland University of Technology Company Overview
5.66.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.67 Refocus Group Inc Company Overview
5.67.1 Refocus Group Inc Pipeline Products & Ongoing Clinical Trials Overview
5.68 RetMap Inc Company Overview
5.68.1 RetMap Inc Pipeline Products & Ongoing Clinical Trials Overview
5.69 Royal College of Surgeons Ireland Company Overview
5.69.1 Royal College of Surgeons Ireland Pipeline Products & Ongoing Clinical Trials Overview
5.70 Seryx Biomedical Inc Company Overview
5.70.1 Seryx Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.71 Shamir Optical Industry Ltd Company Overview
5.71.1 Shamir Optical Industry Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.72 SightGlass Vision Inc Company Overview
5.72.1 SightGlass Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.73 Stanford University Company Overview
5.73.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.74 Tangible Science LLC Company Overview
5.74.1 Tangible Science LLC Pipeline Products & Ongoing Clinical Trials Overview
5.75 TECLens LLC Company Overview
5.75.1 TECLens LLC Pipeline Products & Ongoing Clinical Trials Overview
5.76 Tel Aviv University Company Overview
5.76.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
5.77 The University of New South Wales press Limited Company Overview
5.77.1 The University of New South Wales press Limited Pipeline Products & Ongoing Clinical Trials Overview
5.78 The Wilmer Eye Institute at Johns Hopkins Company Overview
5.78.1 The Wilmer Eye Institute at Johns Hopkins Pipeline Products & Ongoing Clinical Trials Overview
5.79 Tsubota Laboratory Inc Company Overview
5.79.1 Tsubota Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview
5.80 University of California Irvine Company Overview
5.80.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
5.81 University of California San Diego Company Overview
5.81.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
5.82 University of Chicago Medical Center Company Overview
5.82.1 University of Chicago Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.83 University of Florida Company Overview
5.83.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.84 University of Illinois at Chicago Company Overview
5.84.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
5.85 University of New Hampshire Company Overview
5.85.1 University of New Hampshire Pipeline Products & Ongoing Clinical Trials Overview
5.86 University of Oxford Company Overview
5.86.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
5.87 University of Seville Company Overview
5.87.1 University of Seville Pipeline Products & Ongoing Clinical Trials Overview
5.88 University of South Florida Company Overview
5.88.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
5.89 University of Tennessee Company Overview
5.89.1 University of Tennessee Pipeline Products & Ongoing Clinical Trials Overview
5.90 University of Tubingen Company Overview
5.90.1 University of Tubingen Pipeline Products & Ongoing Clinical Trials Overview
5.91 University of Valencia Company Overview
5.91.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
5.92 University of Washington Company Overview
5.92.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview
5.93 Va-st Ltd Company Overview
5.93.1 Va-st Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.94 Verily Life Sciences Company Overview
5.94.1 Verily Life Sciences Pipeline Products & Ongoing Clinical Trials Overview
5.95 Visioneering Technologies Inc Company Overview
5.95.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.96 VISTAKON Pharmaceuticals LLC Company Overview
5.96.1 VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
5.97 Visus Technology Inc Company Overview
5.97.1 Visus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.98 Weill Cornell Medical College Company Overview
5.98.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview
5.99 Western University Company Overview
5.99.1 Western University Pipeline Products & Ongoing Clinical Trials Overview
5.100 Yolia Health Company Overview
5.100.1 Yolia Health Pipeline Products & Ongoing Clinical Trials Overview

6 Vision Care- Recent Developments
6.1 Nov 12, 2020: Bausch + Lomb reports nearly 27 million units of contact lens materials recycled through one by one recycling program
6.2 Oct 08, 2020: EyeCare4Kids partners with 1-800 contacts to launch Sight the World, a virtual vision clinic providing care to underserved children and adults across the globe
6.3 Oct 01, 2020: Essilor and Quisitive employ rapid application development to adapt to new operational norms
6.4 Sep 10, 2020: CooperCompanies and Divisions named one of Fortune's Best Large Workplaces in Manufacturing and Production
6.5 Sep 07, 2020: Pomerantz law firm announces the filing of a class action against Staar Surgical Company and certain officers - STAA
6.6 Sep 07, 2020: Visioneering sees continued recovery
6.7 Sep 04, 2020: EssilorLuxottica : Update on legal proceedings to obtain information from GrandVision
6.8 Sep 01, 2020: Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
6.9 Sep 01, 2020: Dana-Farber collaborates with Mass. Eye and Ear to rebuild damaged corneas using patients' own stem cells for first time in United States
6.10 Aug 27, 2020: Warby Parker inks $245M
6.11 Aug 26, 2020: Versant Health collaborates with Befitting for on-site optical clinics
6.12 Aug 18, 2020: Johnson & Johnson Vision announces new ACUVUE services and resources to enhance contact lens safety, comfort, and accessibility as part of contact lens health week
6.13 Aug 06, 2020: Vanderbilt researchers receive $1.4 million grant to improve outcomes after macular hole repair
6.14 Aug 05, 2020: Research provides update to prevent Blindness and American Academy of Ophthalmology award grants for big data research to improve patient care
6.15 Jul 30, 2020: GrandVision initiates arbitration proceedings against EssilorLuxottica
6.16 Jul 13, 2020: UC Davis Health study finds special filters in glasses help the color blind see colors better
6.17 Jun 30, 2020: Menicon: A business tie-up agreement concluded with China's Wenzhou Medical University
6.18 Jun 25, 2020: SEC charges Novartis with FCPA violations
6.19 Jun 08, 2020: Johnson & Johnson Vision introduces ACUVUE revitaLens multi-purpose disinfecting solution, the company's first contact lens solution in Canada
6.20 May 21, 2020: Aequus announces positive update on dry eye product launch plans
6.21 May 04, 2020: Pixium Vision extends its cash runway with the issue of € 1.25 million new tranche from ESGO and a pre-agreed € 2.5 million French State Guaranteed Loan
6.22 Apr 24, 2020: Menicon announces completion of floor space expansion at its Kakamigahara Plant
6.23 Apr 20, 2020: EssilorLuxottica to prepare for recovery by preserving cash and supporting employees
6.24 Apr 13, 2020: eSight announces corporate low vision assistive technology program for remote employees
6.25 Apr 13, 2020: New research reassures & advises contact lens wearers during COVID-19 pandemic; offers clear facts and hygiene advice
6.26 Apr 13, 2020: STAAR Surgical provides covid-19 business update
6.27 Apr 09, 2020: Corning reorganizes operating structure
6.28 Apr 09, 2020: Envision announces new collaborative research agreement with WSU
6.29 Apr 07, 2020: Alcon provides update on covid-19
6.30 Mar 30, 2020: InnerScope Hearing Technologies to launch hearing loss information centers in Kiosks at 4,618 Walmart Locations Nationwide
6.31 Mar 13, 2020: Bausch Health to reduce debt by approximately $100 million using cash generated from operations
6.32 Mar 06, 2020: Pentax Medical donates USD430,000 worth of medical devices to fight novel corona virus (2019-ncov)
6.33 Mar 04, 2020: Pixium Vision announces Prima System successful activation in first patient in US feasibility study with the new generation of glasses
6.34 Mar 04, 2020: High-Tech contact lenses correct color blindness
6.35 Mar 02, 2020: Alcon showcases contact lens, eye allergy and dry eye innovations as title sponsor of SECO2020
6.36 Mar 02, 2020: Pixium Vision announces publication in Ophthalmology of promising Prima System data in dry AMD
6.37 Feb 26, 2020: STAAR Surgical reports fourth quarter and full year 2019 results
6.38 Feb 26, 2020: NanoString Technologies releases fourth quarter and full year 2019 operating results and provides 2020 financial outlook
6.39 Feb 24, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan notes
6.40 Feb 12, 2020: Ocutrx Vision Technologies COO details impact of wearables on the healthcare industry at Medical Design & Manufacturing West Conference
6.41 Feb 12, 2020: eSight announces new President and CEO
6.42 Feb 07, 2020: CooperCompanies appoints Mark Drury as new vice president, general counsel and corporate secretary and announces Randal L. Golden to retire
6.43 Feb 06, 2020: Mature presbyopes clinical research update presented at Global Specialty Lens Symposium (GSLS)
6.44 Feb 04, 2020: Visioneering Technologies achieves first sale in Singapore as Asian expansion accelerates
6.45 Feb 04, 2020: Santen and Verily establish joint venture to develop and commercialize unique Ophthalmic Devices
6.46 Jan 29, 2020: Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019
6.47 Jan 27, 2020: Bausch + Lomb and TerraCycle partner to launch Canada's first and only contact lens recycling program
6.48 Jan 23, 2020: LumiThera adds Daniel Bertholet to Board of Directors
6.49 Jan 22, 2020: Tangible Science announces successful 2019 and timing for Tangible Boost launch
6.50 Jan 22, 2020: Novartis establishes its new legal entity in Vietnam
6.51 Jan 16, 2020: Mojo Vision developing first true smart contact lens
6.52 Jan 16, 2020: Mojo Vision working with FDA, nonprofit organization to assist people with low vision
6.53 Jan 13, 2020: UPMC first in the U.S. to implant Wireless Retinal Device
6.54 Jan 13, 2020: Pixium Vision announces successful implantation of first patient in the US with the Prima System
6.55 Jan 13, 2020: Bionic Vision Technologies announces interim pilot study results of the BVT Bionic Eye System designed to help the blind achieve greater mobility and independence
6.56 Jan 13, 2020: STAAR Surgical reports preliminary fourth quarter net sales growth of 25%
6.57 Jan 06, 2020: Bausch + Lomb launches expanded parameters for Biotrue ONEday for Astigmatism Daily Disposable Contact Lenses
6.58 Dec 18, 2019: STAAR CFO to retire in 2020
6.59 Dec 16, 2019: Bausch Health Resolves ""Stock Drop"" Litigation initially filed in October 2015
6.60 Dec 11, 2019: St. Johns County public library offers EnChroma Glasses for color blindness as part of color accessibility program
6.61 Dec 11, 2019: Tenth record-breaking year in a row for ZEISS
6.62 Dec 10, 2019: EnChroma launches Scenic Viewers for Color Blindness in Partnership with SeeCoast
6.63 Dec 06, 2019: FDA approves Myopia-slowing contact lens for children
6.64 Dec 05, 2019: Novartis expects to sustain long-term growth with a robust pipeline of 25+ potential blockbusters highlighted at R&D Day
6.65 Dec 05, 2019: CooperCompanies announces fourth quarter and full year 2019 results
6.66 Dec 02, 2019: Pixium Vision and partners publish paper on photovoltaic subretinal prosthesis PRIMA in Nature Biomedical Engineering

7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Vision Care - Pipeline Products by Stage of Development
Table 2: Vision Care - Pipeline Products by Segment
Table 3: Vision Care - Pipeline Products by Territory
Table 4: Vision Care - Pipeline Products by Regulatory Path
Table 5: Vision Care - Pipeline Products by Estimated Approval Date
Table 6: Vision Care - Ongoing Clinical Trials
Table 7: Vision Care Companies - Pipeline Products by Stage of Development
Table 8: Vision Care - Pipeline Products by Stage of Development
Table 9: 2C Tech Corporation Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: SeeQ Device - Product Status
Table 11: SeeQ Device - Product Description
Table 12: 2Eyes vision SL Pipeline Products & Ongoing Clinical Trials Overview
Table 13: SIMVIS GEKK - Product Status
Table 14: SIMVIS GEKK - Product Description
Table 15: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Retinal Prosthesis System With Thermal Imaging - Product Status
Table 17: Retinal Prosthesis System With Thermal Imaging - Product Description
Table 18: Adventus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Corneal Onlay - Product Status
Table 20: Corneal Onlay - Product Description
Table 21: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Biolens - Product Status
Table 23: Biolens - Product Description
Table 24: Contact Lens - Product Status
Table 25: Contact Lens - Product Description
Table 26: Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Evolve - Product Status
Table 28: Evolve - Product Description
Table 29: Evolve 2 - Product Status
Table 30: Evolve 2 - Product Description
Table 31: Ai Kangte Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Multifocal Contact Lens (Muti-Focal RGP) - Myopia - Product Status
Table 33: Multifocal Contact Lens (Muti-Focal RGP) - Myopia - Product Description
Table 34: Multifocal Contact Lens (Muti-Focal RGP) - Ocular Surface Disease - Product Status
Table 35: Multifocal Contact Lens (Muti-Focal RGP) - Ocular Surface Disease - Product Description
Table 36: Multifocal Contact Lens (Muti-Focal RGP) - Vision Correction - Product Status
Table 37: Multifocal Contact Lens (Muti-Focal RGP) - Vision Correction - Product Description
Table 38: Orthokeratology Lens - Myopia - Product Status
Table 39: Orthokeratology Lens - Myopia - Product Description
Table 40: Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Air Optix Plus HydraGlyde Toric Reusable Lens - Product Status
Tgable 42: Air Optix Plus HydraGlyde Toric Reusable Lens - Product Description
Table 43: Dailies Total 1 Colors SiHy Lens - Product Status
Table 44: Dailies Total 1 Colors SiHy Lens - Product Description
Table 45: Dailies Total 1 Precision 1 Toric SiHy Lens - Product Status
Table 46: Dailies Total 1 Precision 1 Toric SiHy Lens - Product Description
Table 47: Weekly WG SiHy Lens - Product Status
Table 48: Weekly WG SiHy Lens - Product Description
Table 49: Allotex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: TransForm Corneal Allograft - Product Status

List of Figures
Figure 1: Vision Care - Pipeline Products by Stage of Development
Figure 2: Vision Care - Pipeline Products by Segment
Figure 3: Vision Care - Pipeline Products by Territory
Figure 4: Vision Care - Pipeline Products by Regulatory Path
Figure 5: Vision Care - Pipeline Products by Estimated Approval Date
Figure 6: Vision Care - Ongoing Clinical Trials

Companies Mentioned
- 2C Tech Corporation Inc
- 2Eyes vision SL
- Advanced Medical Electronics Corp
- Adventus Technology Inc
- Aeon Astron Corporation
- Aequus Pharmaceuticals Inc
- Ai Kangte Medical Technology Co Ltd
- Alcon Inc
- Allotex Inc
- Apeliotus Ophthalmics (Inactive)
- Axcelon Biopolymers Corp.
- Azalea Vision
- Bar-Ilan University
- Bausch & Lomb Inc
- Biel Glasses SL
- Bionic Sight LLC
- Bionic Vision Australia
- Bionic Vision Technologies Pty Ltd
- Bionode LLC
- Clerio Vision Inc
- Consejo Superior de Investigaciones Cientificas
- CooperVision Inc
- Cornea Biosciences
- Corneat Vision Ltd
- DeepOptics
- Euclid Systems Corp
- e-Vision Medical Devices, Inc.
- Eyenovations
- EyeYon Medical
- Forschungszentrum Julich GmbH
- iBionics Inc
- Imperial College London
- Industrial Science & Technology Network Inc
- Innovega Inc
- Institute of Photonic Sciences
- iSTAR Medical SA
- Johns Hopkins University
- Johnson & Johnson Vision Care Inc
- Kubota Vision Inc
- Laclaree Vision
- Lipocoat BV
- Luminopia Inc
- Lynthera Corp
- MAG Optics Inc
- Massachusetts Eye and Ear Infirmary
- McGill University
- McGowan Institute for Regenerative Medicine
- Mercy Health Research
- Meta Biomed Co Ltd
- Mojo Vision Inc
- Monash University
- Nano Retina, Inc.
- National University of Singapore
- Novartis AG
- Ocular Dynamics, LLC
- OcuMedic Inc
- Ocutec Ltd
- Ocutrx Vision Technologies LLC
- Okayama University
- OPIA Technologies SAS
- Oxsight Ltd
- PixelOptics Inc
- Pixium Vision SA
- Pohang University of Science And Technology
- Presbia Plc
- Queensland University of Technology
- Refocus Group Inc
- RetMap Inc
- Royal College of Surgeons Ireland
- Seryx Biomedical Inc
- Shamir Optical Industry Ltd
- SightGlass Vision Inc
- Stanford University
- Tangible Science LLC
- TECLens LLC
- Tel Aviv University
- The University of New South Wales press Limited
- The Wilmer Eye Institute at Johns Hopkins
- Tsubota Laboratory Inc
- University of California Irvine
- University of California San Diego
- University of Chicago Medical Center
- University of Florida
- University of Illinois at Chicago
- University of New Hampshire
- University of Oxford
- University of Seville
- University of South Florida
- University of Tennessee
- University of Tubingen
- University of Valencia
- University of Washington
- Va-st Ltd
- Verily Life Sciences
- Visioneering Technologies Inc
- VISTAKON Pharmaceuticals LLC
- Visus Technology Inc
- Weill Cornell Medical College
- Western University
- Yolia Health